NetScientific upbeat on latest data from portfolio firm ProAxsis
Healthcare intellectual property commercialisation group NetScientific announced on Friday that its portfolio company ProAxsis has received positive early data from the ‘BRIDGE’ study - a major clinical trial funded by the British Lung Foundation and the European Respiratory Society.